Valuation: Ovation Science Inc.

Market Cap 1.15M 810K 715K 677K 611K 77.64M 1.17M 8.11M 3.11M 39.76M 3.04M 2.98M 128M P/E 2024
-2.68x
P/E 2025 -2.26x
Enterprise Value 1.36M 958K 846K 801K 723K 91.83M 1.38M 9.59M 3.68M 47.02M 3.6M 3.52M 151M EV / Sales 2024
13.2x
EV / Sales 2025 25.7x
Free-Float
76.56%
Yield 2024 *
-
Yield 2025 -
1 day-79.67%
3 months-78.57%
6 months-64.62%
Current year-74.58%
Current year 0.01
Extreme 0.007
0.08
1 year 0.01
Extreme 0.007
0.08
3 years 0.01
Extreme 0.007
0.12
5 years 0
Extreme 0.0023
0.12
10 years 0
Extreme 0.0023
0.48
Manager TitleAgeSince
Director of Finance/CFO 63 2023-10-29
Chief Executive Officer 77 2017-10-03
Director TitleAgeSince
Director/Board Member 77 2017-10-03
Director/Board Member 63 2017-10-03
Director/Board Member 86 2018-02-01
Change 5-day change 1-year change 3-year change Capi.($)
-79.67%-.--% - - 812K
-2.05%-1.98%-5.37%-0.40% 344B
-0.34%-2.58%+3.94%-3.50% 230B
-0.26%-2.01%-6.72%+0.74% 131B
-1.32%-1.99%+6.12%+19.98% 68.92B
-.--%+1.25%+21.68% - 46.32B
+0.82%-2.83%-24.77%-23.79% 45.64B
-1.40%-1.12%+8.08%-12.05% 34.4B
-1.70%-7.50%+4.08%-35.82% 34.14B
-1.58%-1.50%-20.57%-19.38% 32.92B
Average -8.50%-1.28%-1.50%-9.28% 107.53B
Weighted average by Cap. -0.19%-1.07%-1.85%-3.07%

Financials

2024 2025
Net sales 113K 79.48K 70.21K 66.45K 59.98K 7.62M 115K 796K 306K 3.9M 299K 292K 12.52M 67.89K 47.66K 42.1K 39.84K 35.97K 4.57M 68.69K 477K 183K 2.34M 179K 175K 7.51M
Net income -456K -320K -283K -268K -242K -30.71M -462K -3.21M -1.23M -15.73M -1.2M -1.18M -50.45M -631K -443K -391K -370K -334K -42.5M -639K -4.44M -1.7M -21.76M -1.67M -1.63M -69.81M
Net Debt 265K 186K 164K 156K 140K 17.85M 268K 1.86M 716K 9.14M 700K 684K 29.32M 211K 148K 131K 124K 112K 14.19M 213K 1.48M 569K 7.27M 556K 544K 23.31M
Logo Ovation Science Inc.
Ovation Science Inc. is a Canada-based drug development company. The Company develops topical and transdermal cannabidiol (CBD)/ tetrahydrocannabinol (THC) and other cannabinoid products which are out-licensed and also distributed under its own brands; ARLO CBD Beauty and InVibe MD (wellness line); all powered by its patented Invisicare skin delivery technology. The Company manufactures, distributes, sells, markets, sub-licenses and promotes products formulated with Invisicare, containing cannabinoids, hemp seed oil or synthetic derivatives of cannabis. The Company has developed topical and transdermal creams and lotions made with CBD, THC and combinations thereof plus hemp seed oil. Invisicare is a patented polymer-based technology for topical and transdermal skincare products. ARLO CBD Beauty offers science-based skincare solutions. Invibe MD offers a health and wellness product line infused with hemp-derived CBD and developed using Invisicare drug delivery technology.
Employees
-